BIOLASE, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Concentrations (Tables)

Concentrations (Tables)

9 Months Ended

Sep. 30, 2018

Risks And Uncertainties [Abstract]

Summary of Net Revenue from Various Products

Revenue from the Company’s products for the three and nine months ended September 30, 2018 and 2017 are as follows (dollars in thousands):

	Three Months Ended																	Nine Months Ended
	September 30,																	September 30,
	2018							2017							2018							2017
Laser systems	$	7,055			64.5	%		$	6,335			58.6	%		$	20,678			62.5	%		$	21,026			61.3	%
Imaging systems		382			3.5	%			1,103			10.2	%			1,336			4.0	%			2,683			7.8	%
Consumables and other		1,902			17.4	%			1,751			16.2	%			6,239			18.9	%			5,494			16.0	%
Services		1,594			14.6	%			1,585			14.7	%			4,848			14.6	%			4,993			14.6	%
License fees and royalties		3			0.0	%			32			0.3	%			9			0.0	%			96			0.3	%
Total revenue	$	10,936			100.0	%		$	10,806			100.0	%		$	33,110			100.0	%		$	34,292			100.0	%